Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

American Cryostem Corp

Healthcare US CRYO

NoneUSD
0.00(0%)

Last update at 2024-05-09T10:34:21.128818Z

Day Range

--
LowHigh

52 Week Range

0.00010.18
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00443M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.57683M
  • Revenue TTM-0.22703M
  • Revenue Per Share TTM-0.004
  • Gross Profit TTM 0.00702M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-09-30 2020-09-30 2019-09-30 2018-09-30 2017-09-30
Type yearly yearly yearly yearly yearly
Date 2021-09-30 2020-09-30 2019-09-30 2018-09-30 2017-09-30
Income before tax -2.87959M -1.17928M -1.08222M -1.49051M -1.22201M
Minority interest - - - 0.00000M 0.00000M
Net income -3.01042M -1.60867M -1.22720M -1.49051M -1.22201M
Selling general administrative 1.76M 0.97M 0.83M 1.46M 1.82M
Selling and marketing expenses 0.00606M 0.03M 0.03M 0.07M 0.03M
Gross profit 0.00702M 0.51M 0.29M 0.81M 1.31M
Reconciled depreciation 0.07M 0.04M 0.03M 0.03M 0.04M
Ebit -2.20531M -0.58908M -0.95515M -1.36896M -0.89708M
Ebitda -2.10972M -0.52162M -0.90818M -1.34198M -0.85960M
Depreciation and amortization 0.10M 0.07M 0.05M 0.03M 0.04M
Non operating income net other - - - 0.00000M 0.00000M
Operating income -2.20531M -0.58908M -0.95515M -1.24022M -1.02008M
Other operating expenses 2.23M 1.15M 1.28M 2.38M 2.76M
Interest expense 0.10M 0.30M 0.13M 0.10M 0.09M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00001M 0.00003M 0.00016M - -
Net interest income -0.10383M -0.39714M -0.13001M -0.09991M -0.09031M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense 0.13M 0.43M 0.14M -0.15038M -0.11162M
Total revenue 0.02M 0.56M 0.32M 1.10M 1.87M
Total operating expenses 2.21M 1.10M 1.24M 2.08M 2.21M
Cost of revenue 0.01M 0.04M 0.03M 0.30M 0.55M
Total other income expense net -0.67428M -0.59021M -0.12707M -0.11808M -0.23462M
Discontinued operations - - - 0.00000M 0.00000M
Net income from continuing ops -2.87959M -1.17928M -1.08222M -1.49051M -1.22201M
Net income applicable to common shares -2.87959M -1.17928M -1.08222M -1.49051M -1.22201M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2021-09-30 2020-09-30 2019-09-30 2018-09-30 2017-09-30
Type yearly yearly yearly yearly yearly
Date 2021-09-30 2020-09-30 2019-09-30 2018-09-30 2017-09-30
Total assets 1.06M 1.48M 1.29M 1.27M 1.01M
Intangible assets 0.37M 0.37M 0.36M 0.34M 0.30M
Earning assets - - - - -
Other current assets 0.09M 0.00500M - 0.05M 0.03M
Total liab 2.90M 1.90M 2.53M 1.97M 2.03M
Total stockholder equity -1.84755M -0.42120M -1.23801M -0.70045M -1.02156M
Deferred long term liab - - - 0.00000M 0.00000M
Other current liab 0.10M 0.02M 0.29M 0.03M 0.81M
Common stock 0.06M 0.06M 0.05M 0.05M 0.04M
Capital stock 0.06M 0.06M 0.05M 0.05M -
Retained earnings -19.27776M -16.39818M -15.21889M -14.13668M -12.64616M
Other liab 0.98M 0.74M 0.90M 0.66M 0.42M
Good will - - - 0.00000M 0.00000M
Other assets 0.01M 0.01M 0.01M 0.01M 0.01M
Cash 0.00824M 0.04M 0.02M 0.07M 0.41M
Cash and equivalents - - - - -
Total current liabilities 1.63M 1.05M 1.29M 1.11M 1.92M
Current deferred revenue 0.12M - 0.02M 0.03M 0.03M
Net debt 1.14M 0.91M 0.98M 0.71M 0.68M
Short term debt 0.86M 0.84M 0.66M 0.58M 1.09M
Short long term debt 0.82M 0.80M 0.62M 0.55M 1.09M
Short long term debt total 1.15M 0.95M 1.00M 0.78M 1.09M
Other stockholder equity 17.37M 15.92M 13.93M 13.68M 11.85M
Property plant equipment 0.23M 0.23M 0.24M 0.24M 0.05M
Total current assets 0.20M 0.57M 0.38M 0.37M 0.64M
Long term investments 0.24M 0.30M 0.30M 0.30M 0.00100M
Net tangible assets -2.21940M -0.78687M -1.60050M -1.03841M -1.32062M
Short term investments - - - 0.00000M 0.00000M
Net receivables 0.08M 0.50M 0.33M 0.22M 0.17M
Long term debt 0.28M 0.00910M 0.10M 0.03M 0.11M
Inventory 0.02M 0.02M 0.03M 0.03M 0.03M
Accounts payable 0.55M 0.18M 0.32M 0.47M 0.22M
Total permanent equity - - - 0.00000M 0.00000M
Noncontrolling interest in consolidated entity - - - 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests - - - 0.00000M 0.00000M
Accumulated other comprehensive income - - -0.28908M -0.28707M -0.26543M
Additional paid in capital - - - 0.00000M 0.00000M
Common stock total equity - - - 0.00000M 0.00000M
Preferred stock total equity - - - 0.00000M 0.00000M
Retained earnings total equity - - - 0.00000M 0.00000M
Treasury stock - - - 0.00000M 0.00000M
Accumulated amortization - - - 0.00000M 0.00000M
Non currrent assets other 0.01M 0.01M 0.01M 0.01M 0.01M
Deferred long term asset charges - - - 0.00000M 0.00000M
Non current assets total 0.86M 0.91M 0.91M 0.90M 0.37M
Capital lease obligations 0.05M 0.04M 0.06M 0.09M 0.00000M
Long term debt total - - - 0.00000M 0.00000M
Breakdown 2021-09-30 2020-09-30 2019-09-30 2018-09-30 2017-09-30
Type yearly yearly yearly yearly yearly
Date 2021-09-30 2020-09-30 2019-09-30 2018-09-30 2017-09-30
Investments -0.09134M -0.01273M -0.04990M -0.30000M -0.30000M
Change to liabilities 0.59M 0.24M 0.10M 0.28M 0.39M
Total cashflows from investing activities -0.09134M -0.01273M -0.04990M -0.52497M -0.07268M
Net borrowings 0.22M 0.14M 0.22M 0.19M -0.01103M
Total cash from financing activities 0.36M 0.55M 0.50M 0.36M 0.11M
Change to operating activities 0.28M -0.16500M 0.29M 0.33M -0.02245M
Net income -2.87959M -1.17928M -1.08222M -1.49051M -1.22201M
Change in cash -0.03352M 0.02M -0.04452M -0.34202M 0.37M
Begin period cash flow 0.04M 0.02M 0.07M 0.41M 0.04M
End period cash flow 0.00824M 0.04M 0.02M 0.07M 0.41M
Total cash from operating activities -0.30392M -0.51465M -0.49696M -0.17447M 0.33M
Issuance of capital stock 0.14M 0.40M 0.28M 0.00000M -
Depreciation 0.07M 0.04M 0.03M 0.03M 0.04M
Other cashflows from investing activities - - - 0.00000M 0.00000M
Dividends paid - - - 0.00000M 0.00000M
Change to inventory 0.00247M 0.00545M 0.00784M -0.00599M -0.00301M
Change to account receivables -0.12115M -0.49650M -0.12377M -0.04616M -0.19107M
Sale purchase of stock - - - 0.00000M 0.00000M
Other cashflows from financing activities 0.22M 0.18M 0.25M 0.37M 0.10M
Change to netincome 1.73M 0.82M 0.22M 0.71M 1.34M
Capital expenditures 0.09M 0.01M 0.05M 0.22M 0.07M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital 0.76M -0.41570M 0.27M 0.55M 0.18M
Stock based compensation 0.90M 0.42M - - -
Other non cash items 0.31M 0.48M 0.28M 0.74M 1.34M
Free cash flow -0.39526M -0.52738M -0.54686M -0.39945M 0.26M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRYO
American Cryostem Corp		 - -% - - - 1258.70 - 1110.26 -0.3221
NVO
Novo Nordisk A/S		 2.69 6.23% 45.88 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 1.60 3.69% 45.00 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 15.16 3.36% 466.79 29.67 24.33 10.38 5.83 9.33 20.00
REGN
Regeneron Pharmaceuticals Inc		 2.56 0.42% 612.50 29.07 20.12 7.57 3.82 6.95 19.42

Reports Covered

Stock Research & News

View All

Profile

American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.

American Cryostem Corp

1 Meridian Road, Eatontown, NJ, United States, 07724

Key Executives

Name Title Year Born
Mr. John S. Arnone Chairman, Pres & CEO 1958
Mr. Anthony Francis Dudzinski Jr. COO, Treasurer, Sec. & Director 1963
Donald Devine CPA Head of Accounting Department & Controller NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.